Cellectar Biosciences Financials - Benzinga

Cellectar Biosciences Inc

CLRBNASDAQ

Trade with Public

Trade with Public

$2.53

-0.01-0.39%

At close: Aug 28, 5:00 PM EST

$2.48

-0.047-1.86%

After Hours: Aug 26, 8:47 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Cellectar Biosciences Financials

Cellectar Biosciences (CLRB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Cellectar Biosciences Q2 EPS $(0.57) Misses $(0.48) Estimate

Cellectar Biosciences (NASDAQ:CLRB) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.48) by 18.75 percent. This is a 83.19 percent increase over losses of $(3.39) per

Benzinga Newsdesk

Earnings Scheduled For May 14, 2026

Benzinga Insights

PRO
Cellectar Biosciences Q1 EPS $(1.33) Beats $(1.89) Estimate. Cash And Equivalents $8.35M

Cellectar Biosciences (NASDAQ:CLRB) reported quarterly losses of $(1.33) per share which beat the analyst consensus estimate of $(1.89) by 29.26 percent. This is a 69.07 percent increase over losses of $(4.30) per share

Benzinga Newsdesk

PRO
Cellectar Biosciences Q4 EPS $(0.53) Beats $(2.29) Estimate

Cellectar Biosciences (NASDAQ:CLRB) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(2.29) by 76.89 percent. This is a 76.67 percent decrease over losses of $(0.30) per share

Benzinga Newsdesk

Earnings Scheduled For March 4, 2026

Benzinga Insights

Insights into Cellectar Biosciences's Upcoming Earnings

Benzinga Insights